Brian D. Lovett

Association of <i>CYP</i> <i>3</i> A <i>4</i> genotype with treatment-related leukemia

Carolyn A. Felix, A. H. C. Walker, Beverly J. Lange et al. · Proceedings of the National Academy of Sciences · 1998 · 312 citations · Full text

t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses <i>MLL</i> with hCDC <i>rel</i> , a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes

Maureen D. Megonigal, Eric Rappaport, Douglas H. Jones et al. · Proceedings of the National Academy of Sciences · 1998 · 160 citations · Full text

Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated <i>MLL</i> Translocation Breakpoints

Brian D. Lovett, Dirk Strumberg, Ian A. Blair et al. · Biochemistry · 2001 · 89 citations

Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at <i>MLL</i> and <i>AF-4</i> genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation

Brian D. Lovett, Luca Lo Nigro, Eric Rappaport et al. · Proceedings of the National Academy of Sciences · 2001 · 84 citations · Full text

MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site

Diana J. Slater, Eva Hilgenfeld, Eric Rappaport et al. · Oncogene · 2002 · 55 citations

Hematological Malignancy, Chromatin, Cytogenetics +13